Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development AMPH Q1 2026 Earnings EPS Misses Estimates as Amphastar Faces Operational Pressures CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue RPC Inc RES Q1 2026 Earnings EPS Beats Estimates by 186 Shares Edge Lower EFX Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher Scholar Rock Q1 2026 Earnings EPS Misses Estimates Amid Continued No Revenue